Shine-On BioMedical Co.,Ltd. (6926.TWO)
TWD 60.0
(0.0%)
TWD 60.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 69.35 Million TWD | 272.59% |
| 2022 | 18.61 Million TWD | 115.83% |
| 2021 | 8.62 Million TWD | 0.0% |
| 2020 | - TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 27 Million TWD | 38.43% |
| 2024 Q2 | 27.14 Million TWD | 0.53% |
| 2023 Q1 | 11.31 Million TWD | -2.04% |
| 2023 FY | 69.35 Million TWD | 272.59% |
| 2023 Q4 | 19.5 Million TWD | 0.0% |
| 2023 Q3 | 19.5 Million TWD | 72.34% |
| 2023 Q2 | 11.31 Million TWD | 0.0% |
| 2022 FY | 18.61 Million TWD | 115.83% |
| 2022 Q4 | 11.55 Million TWD | 0.0% |
| 2022 Q3 | 11.55 Million TWD | 0.0% |
| 2021 FY | 8.62 Million TWD | 0.0% |
| 2020 FY | - TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 45.68% |
| Level Biotechnology Inc. | 151.99 Million TWD | 54.373% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 48.952% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 8.58% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 69.21% |
| GlycoNex Incorporation | 995 Thousand TWD | -6869.849% |
| VBI | 32.55 Million TWD | -113.024% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 73.002% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 64.287% |
| Visgeneer Inc. | 67.48 Million TWD | -2.768% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 118.484% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 86.404% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -8.524% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 95.198% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -136.27% |
| Enimmune corporation | 220.1 Million TWD | 68.492% |
| TaiRx, Inc. | 217.13 Million TWD | 68.061% |
| CHO Pharma, Inc. | 268.99 Million TWD | 74.219% |
| EirGenix Inc. | 236.74 Million TWD | 70.706% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 33.542% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 80.608% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 93.677% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 73.944% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -40.183% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -6303.509% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 60.919% |
| RBC Bioscience Corporation | 58.35 Million TWD | -18.84% |
| BiOptic Inc. | 108.69 Million TWD | 36.196% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -76955.556% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2552.008% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 89.23% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -20979.027% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -50.686% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 42.165% |
| Neith Corporation | 66.87 Million TWD | -3.704% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 25.699% |
| NaviFUS Corp. | 11.82 Million TWD | -486.37% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 63.64% |
| Sinew Pharma Inc. | 186.25 Million TWD | 62.766% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 6.313% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 68.534% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -67.185% |
| AP Biosciences Inc | 32.25 Million TWD | -115.019% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 96.252% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -1214.941% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 78.145% |
| Intech Biopharm Corporation | -163.99 Million TWD | 142.288% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 93.858% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -67.181% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 59.099% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 52.83% |
| TCI GENE Inc. | 174.61 Million TWD | 60.285% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -385177.778% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 76.955% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 76.165% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 17.386% |
| PharmaEngine, Inc. | 441.78 Million TWD | 84.302% |
| Savior Lifetec Corporation | 223.36 Million TWD | 68.953% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 73.201% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 96.561% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 50.061% |
| Acepodia, Inc. | 452.56 Million TWD | 84.676% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 87.18% |